Comparison of Silodosin versus Tadalafil in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

ConclusionsSilodosin achieved significantly greater improvement than tadalafil, with a higher incidence of adverse drug reactions. The risk‐benefit profiles obtained in this study will provide useful information for optimal pharmacological treatment of LUTS/BPH. Our results suggest that silodosin can be one of the first‐line therapies for rapid and efficient relief in patients with LUTS/BPH.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fluts.12177

Source: LUTS: Lower Urinary Tract Symptoms - April 25, 2017 Category: Urology & Nephrology Authors: Masaki YOSHIDA, Hideki ORIGASA, Narihito SEKI Tags: ORIGINAL ARTICLE Source Type: research